The New York City Council has passed a bill which would significantly broaden the scope of the City’s Earned Safe and Sick Time Act (ESSTA). The bill, which was sent to the Mayor late last month, proposes to expand the qualifying reasons employees can use leave, grants additional unpaid leave entitlements, and clarifies collective bargaining agreement waivers.
Read MoreNew York State and City have enacted new requirements for employers in recent weeks. With these recent changes and the summer upon us, now may be an ideal time for employers to review and update their handbook policies and employee notices to ensure full compliance and alignment with the latest requirements.
Read MoreAs previously reported, effective January 1, 2025, New York employers will be required to provide employees with 20 hours of Paid Prenatal Personal Leave during any 52-week period. New York State has now released guidance for employers and employees, as well as FAQs, that employers should consult as they implement the new leave requirement.
Read MoreLast month, New York State passed its budget for fiscal year 2025. The budget expanded New York State’s Paid Sick and Safe Leave Law to require that employers provide 20 hours of paid leave to employees for prenatal medical care, and amended the New York Labor Law to require that employers provide paid break time for employees to express breast milk following childbirth.
Read MoreOn November 21, 2022, Governor Hochul signed a bill amending Section 215 of the New York Labor Law, expanding employee protections by prohibiting discrimination, retaliation, and other adverse employment actions on the basis of an employee’s use of a legally protected absence pursuant to federal, state, or local law.
Read MoreThe employment law landscape is ever-changing when it comes to COVID-19 and compliance issues. This alert summarizes some recent key developments: the dissolution of the stay on the OSHA vaccinate or test mandate, the passage of child vaccination leave for COVID-19 in NYC, and the extension of the designation of COVID-19 as an airborne infectious disease for HERO Act purposes.
Read More